O-serotype conversion in salmonella typhimurium induces protective immune responses against invasive non-typhoidal Salmonella infections

Frontiers in Immunology

Volumn 8, Issue DEC, 2017, Pages

  Li, Pei ^a,b   Liu, Qing ^c   Luo, Hongyan ^a   Liang, Kang ^a   Yi, Jie ^a   Luo, Ying ^a   Hu, Yunlong ^a   Han, Yue ^a   Kong, Qingke ^a,b,d  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b ARIZONA STATE UNIVERSITY   (United States)

^c SOUTHWEST UNIVERSITY   (China)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cross protection; Live attenuated Salmonella vaccine; O antigen; S. Choleraesuis; S. Enteritidis; S. Newport; S. Typhimurium

Indexed keywords

IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; O ANTIGEN; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CELL ADHESION; CELL INVASION; CELL MOTILITY; CHROMOSOME DELETION; CROSS PROTECTION; GENE EXPRESSION; GENE MUTATION; GENETIC ENGINEERING; GENETIC MANIPULATION; IMMUNE RESPONSE; IMMUNOGENICITY; LD50; LETHALITY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; SIGNAL TRANSDUCTION; SILVER STAINING; TYPHOID FEVER; WESTERN BLOTTING;

EID: 85036605930     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01647     Document Type: Article

References (74)

1. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'brien SJ, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis (2010) 50:882-9. doi:10.1086/650733
2. Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health (2012) 2:010401. doi:10.7189/jogh.02.010401
3. Sanderson KE, Nair S. Taxonomy and species concepts in the genus Salmonella. In: Barrow P, Methner U, editors. Salmonella in Domestic Animals. 2 ed. CAB International (2013). p. 1-19. doi:10.1079/9781845939021.0001
4. Gal-Mor O, Boyle EC, Grassl GA. Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ. Front Microbiol (2014) 5:391. doi:10.3389/fmicb.2014.00391
5. Andrews JR, Ryan ET. Diagnostics for invasive Salmonella infections: current challenges and future directions. Vaccine (2015) 33(Suppl 3):C8-15. doi:10.1016/j.vaccine.2015.02.030
6. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet (2012) 379:2489-99. doi:10.1016/S0140-6736(11)61752-2
7. Takem EN, Roca A, Cunnington A. The association between malaria and non-typhoid Salmonella bacteraemia in children in sub-Saharan Africa: a literature review. Malar J (2014) 13:400. doi:10.1186/1475-2875-13-400
8. Fuche FJ, Sow O, Simon R, Tennant SM. Salmonella serogroup C: current status of vaccines and why they are needed. Clin Vaccine Immunol (2016) 23:737-45. doi:10.1128/CVI.00243-16
9. Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine (2015) 33(Suppl 3):C21-9. doi:10.1016/j.vaccine.2015.03.102
10. Simon R, Levine MM. Glycoconjugate vaccine strategies for protection against invasive Salmonella infections. Hum Vaccin Immunother (2012) 8:494-8. doi:10.4161/hv.19158
11. MacLennan CA, Martin LB, Micoli F. Vaccines against invasive Salmonella disease: current status and future directions. Hum Vaccin Immunother (2014) 10:1478-93. doi:10.4161/hv.29054
12. Grabenstein JD, Pittman PR, Greenwood JT, Engler RJ. Immunization to protect the US Armed Forces: heritage, current practice, and prospects. Epidemiol Rev (2006) 28:3-26. doi:10.1093/epirev/mxj003
13. Ivanoff B, Levine MM, Lambert P. Vaccination against typhoid fever: present status. Bull World Health Organ (1994) 72:957
14. Tennant SM, Levine MM. Live attenuated vaccines for invasive Salmonella infections. Vaccine (2015) 33(Suppl 3):C36-41. doi:10.1016/j.vaccine.2015.04.029
15. Pasetti MF, Simon JK, Sztein MB, Levine MM. Immunology of gut mucosal vaccines. Immunol Rev (2011) 239:125-48. doi:10.1111/j.1600-065X.2010.00970.x
16. Mestecky J, Nguyen H, Czerkinsky C, Kiyono H. Oral immunization: an update. Curr Opin Gastroenterol (2008) 24:713-9. doi:10.1097/MOG.0b013e32830d58be
17. Galen JE, Curtiss R. The delicate balance in genetically engineering live vaccines. Vaccine (2014) 32:4376-85. doi:10.1016/j.vaccine.2013.12.026
18. Hindle Z, Chatfield SN, Phillimore J, Bentley M, Johnson J, Cosgrove CA, et al. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun (2002) 70:3457-67. doi:10.1128/IAI.70.7.3457-3467.2002
19. Tennant SM, Wang J-Y, Galen JE, Simon R, Pasetti MF, Gat O, et al. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains. Infect Immun (2011) 79:4175-85. doi:10.1128/IAI.05278-11
20. Curtiss R, Kelly SM. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun (1987) 55:3035-43
21. Liu X, Liu Q, Xiao K, Li P, Liu Q, Zhao X, et al. Attenuated Salmonella typhimurium delivery of a novel DNA vaccine induces immune responses and provides protection against duck enteritis virus. Vet Microbiol (2016) 186:189-98. doi:10.1016/j.vetmic.2016.03.001
22. Li P, Liu Q, Huang C, Zhao X, Roland KL, Kong Q. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge. Vaccine (2017) 35:2862-9. doi:10.1016/j.vaccine.2017.04.002
23. Huang C, Liu Q, Luo Y, Li P, Liu Q, Kong Q. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge. Vaccine (2016) 34:4285-92. doi:10.1016/j.vaccine.2016.07.010
24. Avci FY, Kasper DL. How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol (2010) 28:107-30. doi:10.1146/annurev-immunol-030409-101159
25. Park BS, Lee JO. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med (2013) 45:e66. doi:10.1038/emm.2013.97
26. Svenson S, Nurminen M, Lindberg A. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun (1979) 25:863-72
27. Simon R, Tennant SM, Wang JY, Schmidlein PJ, Lees A, Ernst RK, et al. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis. Infect Immun (2011) 79:4240-9. doi:10.1128/IAI.05484-11
28. Mukkur TK, Stocker BA, Walker KH. Genetic manipulation of Salmonella serotype bovismorbificans to aromatic-dependence and evaluation of its vaccine potential in mice. J Med Microbiol (1991) 34:57-62. doi:10.1099/00222615-34-1-57
29. Nnalue NA, Stocker B. Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect Immun (1987) 55:955-62
30. Jörbeck HJ, Svenson SB, Lindberg AA. Immunochemistry of Salmonella O-antigens: specificity of rabbit antibodies against the O-antigen 4 determinant elicited by whole bacteria and O-antigen 4 specific saccharide-protein conjugates. J Immunol (1979) 123:1376-81
31. Luk J, Lindberg A. Anti-Salmonella lipopolysaccharide monoclonal antibodies: characterization of Salmonella BO-, CO-, DO-, and EO-specific clones and their diagnostic usefulness. J Clin Microbiol (1991) 29:2424-33
32. Carlin NI, Svenson SB, Lindberg AA. Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb Pathog (1987) 2:171-83. doi:10.1016/0882-4010(87)90019-2
33. Hormaeche CE, Mastroeni P, Harrison JA, de Hormaeche RD, Svenson S, Stocker BA. Protection against oral challenge three months after iv immunization of BALBc mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Vaccine (1996) 14:251-9. doi:10.1016/0264-410X(95)00249-Z
34. Blomfield I, Vaughn V, Rest R, Eisenstein B. Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Mol Microbiol (1991) 5:1447-57. doi:10.1111/j.1365-2958.1991.tb00791.x
35. Nakayama K, Kelly SM, Curtiss R. Construction of an Asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Nat Biotechnol (1988) 6:693-7. doi:10.1038/nbt0688-693
36. Dower WJ, Miller JF, Ragsdale CW. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 16:6127-45. doi:10.1093/nar/16.13.6127
37. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. United Kingdom: Coldspring-Harbour Laboratory Press (2001)
38. Edwards RA, Keller LH, Schifferli DM. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene (1998) 207:149-57. doi:10.1016/S0378-1119(97)00619-7
39. Gibson DG, Young L, Chuang R-Y, Venter JC, Hutchison CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods (2009) 6:343-5. doi:10.1038/nmeth.1318
40. Roland K, Curtiss R III, Sizemore D. Construction and evaluation of a Δcya Δcrp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis (1999) 43:429-41. doi:10.2307/1592640
41. Kong Q, Six DA, Roland KL, Liu Q, Gu L, Reynolds CM, et al. Salmonella synthesizing 1-dephosphorylated lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J Immunol (2011) 187:412-23. doi:10.4049/jimmunol.1100339
42. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol (1983) 154:269-77
43. Kong Q, Liu Q, Roland KL, Curtiss R III. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen. Infect Immun (2009) 77:5572-82. doi:10.1128/IAI.00831-09
44. Kong Q, Yang J, Liu Q, Alamuri P, Roland KL, Curtiss R III. Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium. Infect Immun (2011) 79:4227-39. doi:10.1128/IAI.05398-11
45. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol (1938) 27:493-7. doi:10.1093/oxfordjournals.aje.a118408
46. McKay GA, Woods DE, MacDonald KL, Poole K. Role of phosphoglucomutase of stenotrophomonasmaltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun (2003) 71:3068-75. doi:10.1128/IAI.71.6.3068-3075.2003
47. Liu Q, Liu Q, Zhao X, Liu T, Yi J, Liang K, et al. Immunogenicity and cross-protective efficacy induced by outer membrane proteins from Salmonella typhimurium mutants with truncated LPS in mice. Int J Mol Sci (2016) 17:416. doi:10.3390/ijms17030416
48. Wang S, Shi H, Li Y, Shi Z, Zhang X, Baek CH, et al. A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains. Infect Immun (2013) 81:3148-62. doi:10.1128/IAI.00097-13
49. Kong Q, Liu Q, Jansen AM, Curtiss R III. Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Vaccine (2010) 28:6094-103. doi:10.1016/j.vaccine.2010.06.074
50. Micoli F, Rondini S, Pisoni I, Proietti D, Berti F, Costantino P, et al. Vi-CRM 197 as a new conjugate vaccine against Salmonella typhi. Vaccine (2011) 29:712-20. doi:10.1016/j.vaccine.2010.11.022
51. Kossaczka Z, Lin F-YC, Ho VA, Thuy NTT, Van Bay P, Thanh TC, et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2-to 4-year-old children in Vietnam. Infect Immun (1999) 67:5806-10
52. Wacker M, Linton D, Hitchen PG, Nita-Lazar M, Haslam SM, North SJ, et al. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science (2002) 298:1790-3. doi:10.1126/science.298.5599.1790
53. Stimson E, Virji M, Makepeace K, Dell A, Morris HR, Payne G, et al. Meningococcal pilin: a glycoprotein substituted with digalactosyl 2,4-diacetamido-2,4,6-trideoxyhexose. Mol Microbiol (1995) 17:1201-14. doi:10.1111/j.1365-2958.1995.mmi_17061201.x
54. Faridmoayer A, Fentabil MA, Mills DC, Klassen JS, Feldman MF. Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation. J Bacteriol (2007) 189:8088-98. doi:10.1128/JB.01318-07
55. Kowarik M, Young NM, Numao S, Schulz BL, Hug I, Callewaert N, et al. Definition of the bacterial N-glycosylation site consensus sequence. EMBO J (2006) 25:1957-66. doi:10.1038/sj.emboj.7601087
56. Wacker M, Feldman MF, Callewaert N, Kowarik M, Clarke BR, Pohl NL, et al. Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc Natl Acad Sci U S A (2006) 103:7088-93. doi:10.1073/pnas.0509207103
57. Pan C, Sun P, Liu B, Liang H, Peng Z, Dong Y, et al. Biosynthesis of conjugate vaccines using an O-linked glycosylation system. MBio (2016) 7:e443-416. doi:10.1128/mBio.00443-16
58. Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Thony-Meyer L. Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact (2010) 9:61. doi:10.1186/1475-2859-9-61
59. Nothaft H, Szymanski CM. Bacterial protein N-glycosylation: new perspectives and applications. J Biol Chem (2013) 288:6912-20. doi:10.1074/jbc.R112.417857
60. Kong W, Clark-Curtiss J, Curtiss R III. Utilizing Salmonella for antigen delivery: the aims and benefits of bacterial delivered vaccination. Expert Rev Vaccines (2013) 12:345-7. doi:10.1586/erv.13.7
61. Reeves PR, Cunneen MM, Liu B, Wang L. Genetics and evolution of the Salmonella galactose-initiated set of o antigens. PLoS One (2013) 8:e69306. doi:10.1371/journal.pone.0069306
62. Hong Y, Cunneen MM, Reeves PR. The Wzx translocases for Salmonella enterica O-antigen processing have unexpected serotype. Mol Microbiol (2012) 84:620-30. doi:10.1111/j.1365-2958.2012.08048.x
63. Liu B, Knirel YA, Feng L, Perepelov AV, Senchenkova SN, Reeves PR, et al. Structural diversity in Salmonella O antigens and its genetic basis. FEMS Microbiol Rev (2014) 38:56-89. doi:10.1111/1574-6976.12034
64. Samuel G, Reeves P. Biosynthesis of O-antigens: genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr Res (2003) 338:2503-19. doi:10.1016/j.carres.2003.07.009
65. Wollin R, Eriksson U, Lindberg AA. Salmonella bacteriophage glycanases: endorhamnosidase activity of bacteriophages P27, 9NA, and KB1. J Virol (1981) 38:1025-33
66. Toguchi A, Siano M, Burkart M, Harshey RM. Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J Bacteriol (2000) 182:6308-21. doi:10.1128/JB.182.22.6308-6321.2000
67. Liu MA, Stent TL, Hong Y, Reeves PR. Inefficient translocation of a truncated O unit by a Salmonella Wzx affects both O-antigen production and cell growth. FEMS Microbiol Lett (2015) 362. doi:10.1093/femsle/fnv053
68. Udhayakumar V, Muthukkaruppan V. Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice. Infect Immun (1987) 55:816-21
69. Udhayakumar V, Muthukkaruppan V. An outer membrane protein (porin) as an eliciting antigen for delayed-type hypersensitivity in murine salmonellosis. Infect Immun (1987) 55:822-4
70. Liu Q, Liu Q, Yi J, Liang K, Liu T, Roland KL, et al. Outer membrane vesicles derived from Salmonella typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model. Int J Med Microbiol (2016) 306:697-706. doi:10.1016/j.ijmm.2016.08.004
71. Santos RL, Baumler AJ. Cell tropism of Salmonella enterica. Int J Med Microbiol (2004) 294:225-33. doi:10.1016/j.ijmm.2004.06.029
72. Dorsey CW, Raffatellu M, Kingsley RA, Bäumler AJ. Mechanisms of Salmonella enterica serotype typhimurium intestinal colonization. In: Nataro JP, Cohen PS, Mobley HLT, Weiser JN, editors. Colonization of Mucosal Surfaces. Washington, DC: ASM Press (2005). p. 301-12. doi:10.1128/9781555817619.ch21
73. Roudier C, Krause M, Fierer J, Guiney D. Correlation between the presence of sequences homologous to the vir region of Salmonella dublin plasmid pSDL2 and the virulence of twenty-two Salmonella serotypes in mice. Infect Immun (1990) 58:1180-5
74. Kingsley RA, Bäumler AJ. Host adaptation and the emergence of infectious disease: the Salmonella paradigm. Mol Microbiol (2000) 36:1006-14. doi:10.1046/j.1365-2958.2000.01907.x